These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 8594244)

  • 1. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
    Soll AH
    JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.
    Penston JG
    Aliment Pharmacol Ther; 1996 Aug; 10(4):469-86. PubMed ID: 8853751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of peptic ulcers: emerging issues.
    Freston JW
    World J Surg; 2000 Mar; 24(3):250-5. PubMed ID: 10658056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
    Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
    Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract]   [Full Text] [Related]  

  • 19. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
    Tytgat GN
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptic ulcer disease in the 1990s: an Asian perspective.
    Fock KM
    J Gastroenterol Hepatol; 1997 Jun; 12(6):S23-8. PubMed ID: 9195408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.